Hairy cell leukemia differential diagnosis: Difference between revisions

	Hairy cell leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hairy cell leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hairy cell leukemia differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hairy cell leukemia differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hairy cell leukemia differential diagnosis
CDC on Hairy cell leukemia differential diagnosis
Hairy cell leukemia differential diagnosis in the news
Blogs on Hairy cell leukemia differential diagnosis
Directions to Hospitals Treating Hairy cell leukemia
Risk calculators and risk factors for Hairy cell leukemia differential diagnosis

← Older edit Newer edit →

VisualWikitext

Revision as of 01:23, 28 October 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Hairy cell leukemia must be differentiated from other diseases that cause weight loss, fatigue, splenomegaly, and fever, such as chronic lymphocytic leukaemia, prolymphocytic leukaemia, follicular lymphoma, and mantle cell lymphoma.

Differenting Hairy cell leukemia from other Diseases

Hairy cell leukemia must be differentiated from other diseases that cause weight loss, fatigue, splenomegaly, and fever, such as chronic lymphocytic leukaemia, prolymphocytic leukaemia, follicular lymphoma, and mantle cell lymphoma.^[1]


Differential Diagnosis	Surface Immunoglobulin	CD5	CD22/FMC7	CD23	CD79b	CD103

Hairy cell leukaemia	Strongly positive	Negative	Positive	Negative	Positive/Negative	Positive
Chronic lymphocytic leukaemia	Weakly positive	Positive	Negative	Positive	Negative	Positive/Negative
Prolymphocytic leukaemia	Strongly positive	Negative	Positive	Negative	Positive	Negative
Mantle cell lymphoma	Positive	Positive	Strongly positive	Negative	Strongly positive	Negative
Follicular lymphoma	Strongly positive	Negative	Positive	Negative	Strongly positive	Negative

Hairy cell leukemia must also be differentiated from other causes of fever, splenomegaly, and fatigue such as:^[2]

Aplastic anemia
Myelodysplastic syndrome
Splenic marginal zone lymphoma
B-cell prolymphocytic leukemia
Idiopathic myelofibrosis

References

↑ Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011
↑ Hairy Cell Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/Hairy_cell_leukemia#Pathophysiology Accessed on October ,21 2015

Template:WikiDoc Sources

[H-1] Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011

[wiki-2] Hairy Cell Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/Hairy_cell_leukemia#Pathophysiology Accessed on October ,21 2015

[1]

[2]

@@ Line 3: / Line 3: @@
 {{CMG}} {{AE}}{{HL}}
 ==Overview==
-* Hairy cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[fatigue]], [[splenomegaly]], and fever, such as [[chronic lymphocytic leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>
+* Hairy cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[fatigue]], [[splenomegaly]], and fever, such as [[chronic lymphocytic leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].
 ==Differenting Hairy cell leukemia from other Diseases==
@@ Line 9: / Line 9: @@
 <br>
 {| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
-|valign=top|
+| valign="top" |
 |+
 ! style="background: #4479BA; width: 600px;" | {{fontcolor|#FFF|'''Differential Diagnosis'''}}
@@ Line 23: / Line 23: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Hairy cell leukaemia'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Strongly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive/Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
@@ Line 40: / Line 40: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Chronic lymphocytic leukaemia'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center |
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Weakly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center |
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center |
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive/Negative'''
@@ Line 57: / Line 57: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Prolymphocytic leukaemia'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Strongly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
@@ Line 74: / Line 74: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Mantle cell lymphoma'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Strongly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Strongly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
@@ Line 91: / Line 91: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 '''Follicular lymphoma'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Strongly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Strongly positive'''
-| style="padding: 5px 5px; background: #F5F5F5;" align=center|
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
 '''Negative'''
 |}

Hairy cell leukemia differential diagnosis: Difference between revisions

Revision as of 01:23, 28 October 2018

Overview

Differenting Hairy cell leukemia from other Diseases

References

Navigation menu

Search